Mimicry of sorafenib: novel diarylureas as VEGFR2 inhibitors and apoptosis inducers in breast cancer
Magda M. F. Ismail, Ebtehal M. Husseiny, Mona H. Ibrahim
Abstract
Thirteen diarylurea derivatives were designed and synthesized as sorafenib mimetics.
Topics & Concepts
ChemistryBreast cancerInducerMimicryApoptosisSorafenibCancer researchCancerVEGF receptorsInternal medicineBiochemistryZoologyHepatocellular carcinomaGeneBiologyMedicineSynthesis and biological activitySynthesis and Biological ActivityInflammatory mediators and NSAID effects